![](/fileadmin/user_upload/Prof._Andrea_Laghi.jpg)
Prof. Dr. Andrea Laghi
Related Resources
Related Resources
![](/fileadmin/_processed_/c/6/csm_first-frame_AT_8be47331ab.jpg)
Objective, reproducible, and trustworthy data in clinical trials with imaging endpoints
Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials…
![](/fileadmin/_processed_/b/c/csm_STUDY_EVALUATED_RESPONSE_RATE_AND_SAFETY_IN_PATIENTS_WITH_HCC_TREATED_WITH_DEB-TACE_USING_40-um_MICROSPHERES_e6212ebb5f.jpg)
University Hospital Jena: Study evaluated response rate and safety in patients with HCC treated with DEB-TACE using 40-µm microspheres
Researchers at the University Hospital Jena analyzed the response rate and safety of superselective drug-eluting beads transarterial chemoembolization…
![](/fileadmin/_processed_/c/8/csm_STUDY_EXAMINED_CORRELATION_BETWEEN_18F-FDG_PET_AND_CT_TEXTURE_PARAMETERS_IN_METASTATIC_MELANOMA_PATIENTS_1d70b57881.jpg)
University Hospital Tübingen: Study examined correlation between 18f-fdg PET and CT texture parameters in metastatic melanoma patients
An exploratory study [1] conducted by researchers at University Hospital Tuebingen investigated whether CT texture analysis parameters correlate with…